Results 41 to 50 of about 84,091 (291)

Subcutaneous IgG Replacement Therapy by Push in 32 Patients with Primary Immunodeficiency Diseases in Argentine [PDF]

open access: yes, 2014
Introduction: Regular replacement with immunoglobulin infusions is the mainstay of treatment in the majority of primary immunodeficiencies. Several studies showed that Subcutaneous Immunoglobulin (SCIG) has similar efficacy to Intravenous Immunoglobulin (
Bezrodnik, Liliana   +6 more
core   +1 more source

Bronchiectasis

open access: yesOpen Respiratory Archives
Non-cystic fibrosis bronchiectasis, a condition that remains relatively underrecognized, has garnered increasing research focus in recent years. This scientific interest has catalyzed advancements in diagnostic methodologies, enabling comprehensive clinical and molecular profiling.
Beatriz Raboso   +8 more
openaire   +3 more sources

How are the ancient cystic fibrosis patients? Cystic fibrosis diagnosed over 60 years-old

open access: yesRespiratory Medicine Case Reports, 2017
Background and aims: To specify the prevalence of patients diagnosed with CF at age of ≥60 year-old and to analyze their characteristics. Patients and methods: Observational study of CF patients which were diagnosed at age ≥60 year-old.
C. Prados   +10 more
doaj   +1 more source

Bronchiectasis

open access: yesJournal of Physiotherapy, 2011
This 64 page document presents evidencebased clinical practice guidelines on the background, potential causes, clinical assessments, investigations, and management of adults and children with non-CF bronchiectasis. It begins with a 6-page summary of all recommendations.
openaire   +4 more sources

World Bronchiectasis Conference 2025-Inclusive Lungs, Diverse Solutions. [PDF]

open access: yesRespirology
Respirology, Volume 30, Issue 7, Page 552-554, July 2025.
Thomson RM, Morgan LC.
europepmc   +2 more sources

Sputum Microbiota Compositions Correlate With Metabolome and Clinical Outcomes of COPD‐Bronchiectasis Association: A Prospective Cohort Study

open access: yesExploration, EarlyView.
This study aimed to determine how microbiota compositions (via 16S rRNA sequencing) correlate with clinical outcome and metabolome (via liquid chromatography/mass spectrometry) of CBA. Sputum microbiome and metabolome profiles of CBA were well separated from COPD but not bronchiectasis, partly driven by the higher abundance of Proteobacteria in CBA ...
Zhen‐feng He   +16 more
wiley   +1 more source

Bronchiectasis and increased mortality in patients with corticosteroid-dependent severe asthma: a nationwide population study

open access: yesTherapeutic Advances in Respiratory Disease, 2020
Background: Long-term corticosteroid (CS) use is associated with increased mortality in patients with asthma, and comorbid bronchiectasis is also associated with frequent asthma exacerbation and increased healthcare use.
Hayoung Choi   +7 more
doaj   +1 more source

Pulmonary toxicity in children, adolescents, and young adults with testicular germ cell tumors: A population‐based retrospective matched cohort study

open access: yesInternational Journal of Cancer, EarlyView.
What New? Testicular germ cell tumors are highly curable, but the treatments can have lasting impacts. As more young people are surviving these tumors, it is important to understand the lifelong toxicities of these treatments. Here, the authors evaluated the risks of acute and late pulmonary toxicities among children, adolescents, and young adults ...
Rand Ajaj   +8 more
wiley   +1 more source

Draft Genome Sequence of Mycobacterium arupense Strain GUC1. [PDF]

open access: yes, 2015
We report the draft genome sequence of Mycobacterium arupense strain GUC1 from a sputum sample of a patient with bronchiectasis.
Chiu, Charles Y   +5 more
core   +2 more sources

A Systematic Review of the Variability of Ventilation Defect Percent Generated From Hyperpolarized Noble Gas Pulmonary Magnetic Resonance Imaging

open access: yesJournal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Hyperpolarized (HP) gas pulmonary MR ventilation images are typically quantified using ventilation defect percent (VDP); however, the test‐retest variability of VDP has not been systematically established in multi‐center trials. Herein, we perform a systematic review of the test‐retest literature on the variability of VDP, and similar metrics,
Vanessa M. Diamond   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy